The article discusses President Trump’s efforts to lower the cost of In Vitro Fertilisation (IVF) through insurance guidance and drug agreements. The administration plans to issue guidance that would allow employers to offer IVF coverage as a benefit of company insurance plans. They also announced an agreement to reduce the cost of a popular fertility drug, Gonal-F, with EMD Serono, the world’s largest fertility drug manufacturer. These decisions aim to expand access to IVF and reduce the financial burden on those seeking fertility treatment. However, the guidance does not compel employers to offer fertility benefits.